The A4928 is an N-channel power MOSFET driver capable of controlling MOSFETs connected in a half-bridge arrangement and is specifically designed for automotive applications with high-power inductive loads, such as brush DC motors solenoids, actuators, fuel pumps and Integrated starter-generator systems.
The A4928 is intended for ASIL certified automotive systems that interface with a 5V microprocessor. Input thresholds are designed to be compatible with 5V CMOS logic. In common with other Allegro A2SIL™ products, this device incorporates features to complement proper system design, allowing users to achieve the required ASIL level.
A unique charge pump regulator provides full gate drive for battery voltages down to 5.5 V for most applications. A bootstrap capacitor is used to provide the above-battery supply voltage required for N-channel MOSFETs.
The half bridge can be controlled by independent logic-level inputs or through the SPI-compatible serial interface. The external power MOSFETs are protected from shoot-through by a programmable dead time.
Integrated diagnostics provide indication of multiple internal faults, system faults, and power bridge faults, and can be configured to protect the power MOSFETs under most short-circuit conditions.
In addition to providing full access to the bridge control, the serial interface is also used to alter programmable settings such as dead time, VDS threshold, and fault blank time. Detailed diagnostic information can be read through the serial interface.
The A4928 is supplied in a 24-lead eTSSOP (suffix LP). This package is lead (Pb) free, with 100% matte tin leadframe plating (suffix –T).
|Part Number||Package Type||Temperature||RoHS
|Part Composition /
|A4928KLPTR-T||24-lead TSSOP||-40°C to 125°C||Yes||View Data||Contact your
local sales rep
|APEK4928KLP-01-T||DEMO BOARD||-40°C to 125°C||No||--||Contact your
local sales rep
Allegro’s products are not to be used in any devices or systems, including but not limited to life support devices or systems, in which a failure of Allegro’s product can reasonably be expected to cause bodily harm.